#HVO hVIVO PLC – hMPV challenge model update January 13, 2025 – Posted in: hVIVO (HVO)

Highlights · hVIVO successfully completes pilot hMPV characterisation study · Study exhibited strong infectivity rate and induced symptomatic disease in healthy volunteers · Now marketing for hMPV challenge trials to support the development of hMPV vaccines and antivirals · Dr Andrew Catchpole to present data from the study at the 13th International RSV Symposium in Brazil hVIVO plc (AIM: HVO), a fast-growing specialist contract research organisation (CRO) and world leader in testing infectious and…

hVIVO #HVO – hMPV human challenge model June 28, 2023 – Posted in: hVIVO (HVO)

hVIVO plc (AIM & Euronext: HVO), (formerly Open Orphan plc) a rapidly growing specialist contract research organisation and world leader in testing infectious and respiratory disease products using human challenge clinical trials, is developing a human metapneumovirus (hMPV) challenge model. hVIVO has signed an agreement with a North American biopharmaceutical company to manufacture a hMPV virus and conduct a characterisation study, with the intent to conduct a subsequent hMPV challenge trial in 2024 to test…

#HVO hVIVO PLC – hMPV challenge model update January 13, 2025 – Posted in: hVIVO (HVO)

hVIVO #HVO – hMPV human challenge model June 28, 2023 – Posted in: hVIVO (HVO)

Address

Contact

Social

LEGAL